Patent · US Active

Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists

US10660964B2 · kind B2 · utility

0Cited by
1References
8Claims
0Family size

Assignee

Inventor

Key dates

Filing dateOct 19, 2018
Grant dateMay 26, 2020
Priority date
Expiry dateOct 19, 2038

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB82Y5/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a pharmaceutical composition in the form of a storage-stable solution for the parenteral administration of ultrashort-effective β-adrenoreceptor antagonists, comprising a) an ultrashort-effective β-adrenoreceptor antagonist and/or a pharmaceutically acceptable salt thereof, b) water, and c) a cyclodextrin and/or a functional cyclodextrin derivative. The composition according to the invention has high stability, even without the presence of additional adjuvants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.